Loading, Please Wait...
NEWBURYPORT, Mass., May 07, 2019 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today reported net income of $3.7 million or $0.50 per diluted common share outstanding for its first quarter ended March 31, 2019, compared to net income of $1.8 million or $0.24 per diluted common share outstanding for the same quarter in 2018. Sales for the first quarter were $47.3 million compared to 2018 first quarter sales of $42.9 million.
"I am pleased with our first quarter results and continued progress," said R. Jeffrey Bailly, chairman & CEO. "A 10% rise in sales, coupled with continued improvements in our operating efficiency, drove a healthy increase in our gross margins and helped us more than double net income.”
"During the quarter, we launched a substantial new medical program and ramped up volumes of existing programs, all of which contributed to a 19% increase in our medical sales,” Bailly continued. “We are also seeing solid growth in our aerospace and defense business.”
"Looking ahead, with recently awarded new business, a robust pipeline of new opportunities for both internal growth and growth through acquisitions, and some exciting new additions to our team, we are bullish about the future," Bailly said.
Financial Highlights for Q1 2019:
UFP Technologies is an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market. Utilizing highly specialized foams, films and plastics, the Company converts raw materials through laminating, molding, radio frequency welding and fabricating techniques. The Company is diversified by also providing highly engineered solutions to customers in the aerospace & defense, automotive, consumer, electronics and industrial markets.
This news release contains statements relating to expected financial performance and/or future business prospects, events and plans that are forward-looking statements. Such statements include, but are not limited to, statements regarding the Company’s participation and growth in multiple markets and new program launches, statements indicating that the Company may be able to sustain or increase its sales, earnings and earnings per share or sales, earnings and earnings per share growth rates, statements about the Company’s acquisition strategies and opportunities, statements regarding anticipated trends in the different markets in which the Company competes and expectations regarding customer demand, anticipated advantages the Company expects to realize from its investments and capital expenditures, expectations regarding the manufacturing capacity and efficiencies of the Company, expectations regarding the Company’s liquidity, its business opportunities, the Company’s growth potential and strategies for growth, anticipated revenues and the timing of such revenues. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation, the identification of suitable acquisition candidates and the successful, efficient execution of acquisition transactions and integration of any acquisition candidates, risks and uncertainties associated with the anticipated growth of the Company’s business and increases to sales, earnings and earnings per share, as well as other risks and uncertainties that are detailed in the documents filed by the Company with the SEC. Accordingly, actual results may differ materially. Readers are referred to the documents filed by the Company with the SEC, specifically the last reports on Forms 10-K and 10-Q. The forward-looking statements contained herein speak only of the Company’s expectations as of the date of this press release. The Company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statement to reflect any change in the Company’s expectations or any change in events, conditions, or circumstances on which any such statement is based.
Consolidated Condensed Statements of Income
(in thousands, except per share data)
|Three Months Ended|
|Cost of sales||34,831||32,746|
|Gain on sale of fixed assets||-||(40)|
|Interest expense, net||231||248|
|Other expense (income)||239||(50)|
|Income before income taxes||4,783||2,366|
|Net income per share||$||0.50||$||0.24|
|Net income per diluted share||$||0.50||$||0.24|
|Weighted average common shares outstanding||7,402||7,300|
|Weighted average diluted common shares outstanding||7,466||7,378|
Consolidated Condensed Balance Sheets
|March 31,||December 31,|
|Cash and cash equivalents||$||2,493||$||3,238|
|Other current assets||3,346||4,491|
|Net property, plant, and equipment||57,455||57,667|
|Intangible assets, net||21,918||22,232|
|Liabilities and equity:|
|Current portion of long-term debt||$||2,857||$||2,857|
|Other current liabilities||10,076||10,965|
|Long-term debt, excluding current portion||19,286||22,286|
|Total stockholders' equity||144,499||140,457|
|Total liabilities and stockholders' equity||$||192,663||$||189,598|